The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Cando it’s just finished 25% down after your tip !!
The whole Amazon saga is a right mess . As if we need any more reason to doubt our investments here . Something just don’t smell right to me !!!
And it isn’t my socks this time
Here is a link to actual mask page.
It has 4 main suppliers currently
https://pro-larva.com/
imed at all types of industry, from hospital and care homes, to schools, to the retail & leisure industries, Pro-Larva differs from conventional masks because, as well as protecting those around the wearer, it protects the wearer themselves, using copper nanoparticle technology developed in the UK.
Antony Legge, chairman of the parent company Pharm2Farm said: “Conventional surgical-type TR2 masks only block virus from exiting the mask – they don’t have an active mechanism for killing it once it’s trapped in the mask. Pro-Larva has been designed to use existing barrier technology but also to combine it with a-virion, a copper nanoparticle technology that kills 99.9% of the virus once it is trapped in the mask.”
This viricidal layer is effective for up to seven hours. Current surgical masks are only effective for around two hours, which requires health care professionals in Intensive Care Units (ICUs) to wear between four to ten masks per day.
Because of Pro-Larva’s longer effective life this can reduce the number of masks required, therefore reducing costs for the hospital or care home. Pro-Larva is also self-sterilising – killing COVID-19 on contact means there is no infection risk from discarded masks after use, removing any potential biohazard.
The effectiveness of the mask against Coronavirus and Influenza has been tested by an independent laboratory and a leading UK university. It has also received European regulatory approval and carries a CE mark.
The Pro-Larva idea was developed by scientists at Pharm2Farm led by Dr Gareth Cave. Pharm2Farm recently installed a face mask production line in Nottingham, UK and are working with European and global face mask manufacturers to scale-up the supply of Pro-Larva to meet demand.
Dr Gareth Cave, founder of the technology and Pharm2Farm, said: “Helping healthcare professionals protect themselves, their co-workers and patients is very important, and we are keen to support the NHS. However, there are many other categories of frontline workers we are looking to engage with – from schools to care home workers, to the retail and leisure industries – who could benefit from this next generation mask.”
From the Innovate UK grant issued by Gov.....
The development of a nanotechnology enabled anti-viral face mask (NanoMask)
Lead Participant: Pharm 2 Farm Limited
A survey conducted by the British Medical Association found that half of doctors working in high risk environments do not have access to appropriate face masks. Also, the British Dental Association has lamented the typical UK dentist who can go through 250 face masks per week is now restricted to 100 no matter the practice size. A study by HSE and PHE on the use of PPE in health care settings published on the 27th of March recommended the use of FFP3 but if not available FFP2 and N95 masks can be used. However, there is no certified manufacturing of face masks in the UK and there is only one manufacturer of spunbond and meltblown nonwoven medical fabrics, a material used for FFP2/N95 disposable respirators.
Pharm2Farm and Gareth Cave to the Rescue!!! These masks and further ones will become the new GOLD STANDARD for medical professionals.
Am looking forwards to a superb couple of weeks , months and years ahead being invested in this game changing company :)
Some big positives soon to land reference contracts
Most recent RNS...
"the purchase order with Volz coupled with the intentions by both parties to enter into a more formal outsourced manufacturing agreement, means P2F can commence sales with confidence as we anticipate a continuing market need for P2F's proprietary a-virion material, notwithstanding the progress of various national Covid-19 vaccination programmes."
Just watching the ITV news from a few weeks ago and the pack of 10 masks were def coming off the production line at about 1 pack every 5 seconds!!!!
So that's equivalent of a mask every half a second!!! Which if run 24/7 does indeed work out at 5 million a month!!
Fantastic news and something that not everybody has spotted!!
Looking forwards to a great week :)
https://twitter.com/magnesiumhc/status/1371854543936446466?s=21
Good to see the new Board is maintaining shareholder value and keeping open communications .
This share is really testing me now :(
Keee was it just the machine figures that made you change your mind ?
Kneee- Are you invested here ? You certainly seemed keen on 24th January ?
“TB24 Jan 2021 12:24”
The only thing putting a little doubt in peoples minds here is TB, once he has sold out and kicked off the BOD their will be no stopping this share.
Like someone said earlier, there is an absolutey huge market for retail, the airline industry, concerts, theatre, sporting events and the list goes on......
Doesn't matter if the Masks are 3, 4 or 5 ply as long as they work, not ramping but can see 20p + if the BOD can do the right things here.
Good luck all.....
Star are you ok ?? You seem very desperate and your shameful ramping has mislead lots of people .
Your post from earlier when it was at 85p
No Opinion
“HUGE BUYS COMING IN01 Mar 2021 11:53
2.8 million buy !!! its GONNA BLOW Get in while you can !“
I think you need to relax and take stock of the situation old boy